TY - JOUR
T1 - Critical Analysis of Genome-Wide Association Studies
T2 - Triple Negative Breast Cancer Quae Exempli Causa
AU - Jurj, Maria Ancuta
AU - Buse, Mihail
AU - Zimta, Alina Andreea
AU - Paradiso, Angelo
AU - Korban, Schuyler S.
AU - Pop, Laura Ancuta
AU - Berindan-Neagoe, Ioana
N1 - Funding Information:
This research was funded by the Funding Agency?Ministry of Research and Innovation, through the project PNCDI III 2015?2020 ?Increasing the performance of scientific research and technology transfer in translational medicine through the formation of a new generation of young researchers?; ECHITAS, by the Executive Unit for Financing Higher Education, Research, Development, and Innovation (UEFISCDI), Romania, project title: ?Addressing the complex exposome profile in hormone-dependent cancers of the breast and prostate and its influence on tumoral genome?; ACHILLE, grant ID: PN-III-P4-ID-PCE-2016-0795; no. 164/2017; POSCCE 709/2010 grant with the title, ?Clinical and economical impact of proteome and transcriptome molecular profiling in neoadjuvant therapy of triple negative breast cancer (BREASTIMPACT)?; as well as Maria-Ancuta Jurj won a scholarship from the European Social Found, Human Capital Operational Programme 2014-2020, project no. POCU/380/6/13/125171.
Funding Information:
Funding: This research was funded by the Funding Agency—Ministry of Research and Innovation, through the project PNCDI III 2015–2020 “Increasing the performance of scientific research and technology transfer in translational medicine through the formation of a new generation of young researchers”; ECHITAS, by the Executive Unit for Financing Higher Education, Research, Development, and Innovation (UEFISCDI), Romania, project title: “Addressing the complex exposome profile in hormone-dependent cancers of the breast and prostate and its influence on tumoral genome”; ACHILLE, grant ID: PN-III-P4-ID-PCE-2016-0795; no. 164/2017; POSCCE 709/2010 grant with the title, “Clinical and economical impact of proteome and transcriptome molecular profiling in neoadjuvant therapy of triple negative breast cancer (BREASTIMPACT)”; as well as Maria-Ancuta Jurj won a scholarship from the European Social Found, Human Capital Operational Programme 2014-2020, project no. POCU/380/6/13/125171.
PY - 2020/8/14
Y1 - 2020/8/14
N2 - Genome-wide association studies (GWAS) are useful in assessing and analyzing either differences or variations in DNA sequences across the human genome to detect genetic risk factors of diseases prevalent within a target population under study. The ultimate goal of GWAS is to predict either disease risk or disease progression by identifying genetic risk factors. These risk factors will define the biological basis of disease susceptibility for the purposes of developing innovative, preventative, and therapeutic strategies. As single nucleotide polymorphisms (SNPs) are often used in GWAS, their relevance for triple negative breast cancer (TNBC) will be assessed in this review. Furthermore, as there are different levels and patterns of linkage disequilibrium (LD) present within different human subpopulations, a plausible strategy to evaluate known SNPs associated with incidence of breast cancer in ethnically different patient cohorts will be presented and discussed. Additionally, a description of GWAS for TNBC will be presented, involving various identified SNPs correlated with miRNA sites to determine their efficacies on either prognosis or progression of TNBC in patients. Although GWAS have identified multiple common breast cancer susceptibility variants that individually would result in minor risks, it is their combined effects that would likely result in major risks. Thus, one approach to quantify synergistic effects of such common variants is to utilize polygenic risk scores. Therefore, studies utilizing predictive risk scores (PRSs) based on known breast cancer susceptibility SNPs will be evaluated. Such PRSs are potentially useful in improving stratification for screening, particularly when combining family history, other risk factors, and risk prediction models. In conclusion, although interpretation of the results from GWAS remains a challenge, the use of SNPs associated with TNBC may elucidate and better contextualize these studies.
AB - Genome-wide association studies (GWAS) are useful in assessing and analyzing either differences or variations in DNA sequences across the human genome to detect genetic risk factors of diseases prevalent within a target population under study. The ultimate goal of GWAS is to predict either disease risk or disease progression by identifying genetic risk factors. These risk factors will define the biological basis of disease susceptibility for the purposes of developing innovative, preventative, and therapeutic strategies. As single nucleotide polymorphisms (SNPs) are often used in GWAS, their relevance for triple negative breast cancer (TNBC) will be assessed in this review. Furthermore, as there are different levels and patterns of linkage disequilibrium (LD) present within different human subpopulations, a plausible strategy to evaluate known SNPs associated with incidence of breast cancer in ethnically different patient cohorts will be presented and discussed. Additionally, a description of GWAS for TNBC will be presented, involving various identified SNPs correlated with miRNA sites to determine their efficacies on either prognosis or progression of TNBC in patients. Although GWAS have identified multiple common breast cancer susceptibility variants that individually would result in minor risks, it is their combined effects that would likely result in major risks. Thus, one approach to quantify synergistic effects of such common variants is to utilize polygenic risk scores. Therefore, studies utilizing predictive risk scores (PRSs) based on known breast cancer susceptibility SNPs will be evaluated. Such PRSs are potentially useful in improving stratification for screening, particularly when combining family history, other risk factors, and risk prediction models. In conclusion, although interpretation of the results from GWAS remains a challenge, the use of SNPs associated with TNBC may elucidate and better contextualize these studies.
KW - Breast cancer
KW - CNVs
KW - GWAS
KW - Linkage disequilibrium
KW - Predictive risk scores
KW - SNPs
KW - Structural variants
KW - TNBC
UR - http://www.scopus.com/inward/record.url?scp=85089684753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089684753&partnerID=8YFLogxK
U2 - 10.3390/ijms21165835
DO - 10.3390/ijms21165835
M3 - Article
C2 - 32823908
SN - 1661-6596
VL - 21
SP - 1
EP - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 16
M1 - 5835
ER -